Your browser doesn't support javascript.
loading
Pharmacovigilance database search discloses ClC-K channels as a novel target of the AT1 receptor blockers valsartan and olmesartan.
Imbrici, Paola; Tricarico, Domenico; Mangiatordi, Giuseppe Felice; Nicolotti, Orazio; Lograno, Marcello Diego; Conte, Diana; Liantonio, Antonella.
Afiliação
  • Imbrici P; Department of Pharmacy - Drug Sciences, University of Bari 'Aldo Moro', Bari, Italy.
  • Tricarico D; Department of Pharmacy - Drug Sciences, University of Bari 'Aldo Moro', Bari, Italy.
  • Mangiatordi GF; Department of Pharmacy - Drug Sciences, University of Bari 'Aldo Moro', Bari, Italy.
  • Nicolotti O; Department of Pharmacy - Drug Sciences, University of Bari 'Aldo Moro', Bari, Italy.
  • Lograno MD; Department of Pharmacy - Drug Sciences, University of Bari 'Aldo Moro', Bari, Italy.
  • Conte D; Department of Pharmacy - Drug Sciences, University of Bari 'Aldo Moro', Bari, Italy.
  • Liantonio A; Department of Pharmacy - Drug Sciences, University of Bari 'Aldo Moro', Bari, Italy.
Br J Pharmacol ; 174(13): 1972-1983, 2017 07.
Article em En | MEDLINE | ID: mdl-28334417

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tetrazóis / Canais de Cloreto / Bloqueadores do Receptor Tipo 1 de Angiotensina II / Farmacovigilância / Valsartana / Imidazóis Limite: Humans Idioma: En Revista: Br J Pharmacol Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tetrazóis / Canais de Cloreto / Bloqueadores do Receptor Tipo 1 de Angiotensina II / Farmacovigilância / Valsartana / Imidazóis Limite: Humans Idioma: En Revista: Br J Pharmacol Ano de publicação: 2017 Tipo de documento: Article